COmmunity Mistrust and Measures of Institutional Trustworthiness (COMMIT)

社区不信任和机构可信度措施 (COMMIT)

• 批准号: 10545060
• 负责人: C. DANIEL MULLINS
• 金额: $ 59.13万
• 依托单位: UNIVERSITY OF MARYLAND BALTIMORE
• 依托单位国家: 美国
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-01-01 至 2023-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10545060
• 关键词: Address; Affect; Asthma; Baltimore; Baptist Church; Behavior; Behavioral; COVID-19; COVID-19 disparity; COVID-19 impact; COVID-19 morbidity; COVID-19 mortality; COVID-19 pandemic; COVID-19 prevention; COVID-19 susceptibility; COVID-19 testing; Centers for Disease Control and Prevention (U.S.); Clinical Research; Collaborations; Communication; Communities; Contracts; Data Reporting; Diabetes Mellitus; Disasters; Discrimination; Economics; Emotional; Ethics; Fostering; Foundations; Funding; Future; Goals; Grant; Health; Health Disparities Research; Healthcare; Healthcare Systems; Hypertension; Infrastructure; Institution; Lebanon; Light; Maryland; Measures; Medical; Methods; Modeling; Morbidity - disease rate; National Center for Advancing Translational Sciences; National Institute on Minority Health and Health Disparities; Obesity; Outcome; Patients; Pharmacy Schools; Pharmacy facility; Population; Population Group; Public Health; RADx Underserved Populations; Recommendation; Research; Research Personnel; Resources; Risk; Running; SARS-CoV-2 infection; Seminal; Testing; Training Programs; Translational Research; Treatment Effectiveness; Trust; Underrepresented Populations; Underserved Population; United States; United States National Institutes of Health; Universities; Virginia; Vulnerable Populations; Work; Workforce Development; behavior change; community engaged research; community organizations; disparity reduction; effectiveness evaluation; ethnic minority population; fighting; financial relationship; health care delivery; health disparity; health equity; improved; infection rate; insight; inter-institutional; lens; long-standing disparities; medical vulnerability; member; mortality; pandemic disease; patient oriented; population health; preference; public health emergency; racial bias; racial minority population; racism; shared decision making; social; social health determinants; social vulnerability; treatment program; trustworthiness; uptake

PROJECT SUMMARY/ABSTRACT In the United States underserved and socially vulnerable populations have endured higher rates and disparities of COVID-19 infection, morbidity, and mortality. This disproportionate burden has shown the light on the root causes of COVID-19 disparities such as longstanding systemic racial bias in health care delivery, discrimination, and poor social determinants of health that lead to health disparities for medical conditions such as asthma, diabetes, hypertension, and obesity, all of which increase risk and susceptibility to COVID-19 and its sequalae. To address these root causes, academic and other research institutions and health care systems must shift their lens from one that focuses solely on changing behaviors among underserved and vulnerable populations. Behaviors among health care and research institutions must change to breakdown the structural barriers to trust, testing, treatment, and prevention of COVID-19. Prior to asking patients and community members to trust in research and researchers, the focus should be on radical institutional transformation to advance trustworthiness. Trying to address social, ethical, and behavioral issues (SEBI) influencing access acceptability and uptake of COVID-19 testing during a pandemic is extremely challenging, yet achievable when there are existing community-academic partnerships. The distinction between trust and trustworthiness suggests that trustworthiness is an antecedent to trust. Our proposed study will employ a continuous engagement approach to advance institutional trustworthiness and improve the strength of an existing community-engaged research (CEnR) partnership as well as develop recommendations for the formation of similar inter-institutional partnerships with community organizations in underserved populations. In collaboration with community and community-based pharmacy partners, our Aims are: Aim 1: Codesign a sustainable model for trustworthy CEnR partnerships to address SEBI of COVID-19 testing Aim 2: Assess best practices of trustworthy CEnR partnerships to address COVID-19 testing SEBI factors Aim 3: Codevelop an ethically-congruent memorandum of commitment (MOC) template for CEnR partnerships for COVID-19 testing to advance trust through trustworthiness, transparency, and respect

项目总结/文摘